Pure Global

"Kabi" Amex blood component separator - Taiwan Registration 3c1f0cab9eb395e6e0b08bade2683f6b

Access comprehensive regulatory information for "Kabi" Amex blood component separator in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3c1f0cab9eb395e6e0b08bade2683f6b and manufactured by FRESENIUS KABI WARRENDALE;; Fresenius Kabi AG. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
3c1f0cab9eb395e6e0b08bade2683f6b
Registration Details
Taiwan FDA Registration: 3c1f0cab9eb395e6e0b08bade2683f6b
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Kabi" Amex blood component separator
TW: โ€œๅกๆฏ”โ€ๆ„›็พŽๅ…‹ๆ–ฏ่ก€ๆถฒๆˆไปฝๅˆ†้›ขๆฉŸ
Risk Class 2

Registration Details

3c1f0cab9eb395e6e0b08bade2683f6b

DHA00602204300

Company Information

United States;;Germany

Product Details

For details, it is Chinese approved copy of the imitation order

B Hematology, pathology, and genetics

B.9245 Automated hemocytoseparator

Input;; Contract manufacturing

Dates and Status

Jan 17, 2011

Jan 17, 2026